Parallel Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Parallel Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3	Closed	–	–	2815
2020 Q3	$0	Sell	3 -3	-50%	-$319	﹤0.01%	2743
2020 Q2	$0	Buy	+6	New	+$501	﹤0.01%	2823
2019 Q4	–	Sell	-570	Closed	-$30K	–	2553
2019 Q3	$30K	Hold	570	–	–	﹤0.01%	1189
2019 Q2	$29K	Hold	570	–	–	﹤0.01%	1117
2019 Q1	$30K	Hold	570	–	–	﹤0.01%	1063
2018 Q4	$27K	Hold	570	–	–	﹤0.01%	961
2018 Q3	$37K	Hold	570	–	–	﹤0.01%	925
2018 Q2	$28K	Hold	570	–	–	﹤0.01%	928
2018 Q1	$28K	Buy	+570	New	+$29.6K	﹤0.01%	883

Parallel Advisors's MYOK Position: Q4 2020 in Review

Parallel Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 3 shares.

Parallel Advisors first reported a position in MYOK in Q1 2018 and held it in 9 quarters. The position peaked at $37K in Q3 2018. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Parallel Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Parallel Advisors sold 3 MyoKardia, Inc. Common Stock shares in Q4 2020.
Parallel Advisors first reported a position in MyoKardia, Inc. Common Stock in Q1 2018 and held it in 9 quarters.
Parallel Advisors's MyoKardia, Inc. Common Stock position peaked at $37K in Q3 2018.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Parallel Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.